Analytical Data
-
Gene name
HRASLS5
- Application
-
Alternative Names
PLAAT5; HRASLS5; HRLP5; Phospholipase A and acyltransferase 5; Ca(2+)-independent N-acyltransferase; iNAT; EC 2.3.1.-; EC 3.1.1.32; EC 3.1.1.4; H-rev107-like protein 5; HRAS-like suppressor 5; HRSL5
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96KN8
-
Expression Region
1-279aa
-
AA Sequence
MGLSPGAEGE YALRLPRIPP PLPKPASRTA STGPKDQPPA LRRSAVPHSG LNSISPLELE ESVGFAALVQ LPAKQPPPGT LEQGRSIQQG EKAVVSLETT PSQKADWSSI PKPENEGKLI KQAAEGKPRP RPGDLIEIFR IGYEHWAIYV EDDCVVHLAP PSEEFEVGSI TSIFSNRAVV KYSRLEDVLH GCSWKVNNKL DGTYLPLPVD KIIQRTKKMV NKIVQYSLIE GNCEHFVNGL RYGVPRSQQV EHALMEGAKA AGAVISAVVD SIKPKPITA
-
Molecular Weight
30.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HRASLS5, a member of the HRAS-like family of proteins, has gained attention due to its potential role in various biological processes and disease mechanisms. This protein is implicated in the regulation of lipid metabolism, cellular signaling, and development. Recent studies suggest that HRASLS5 may play a significant role in cancer biology, particularly in the modulation of cell proliferation and apoptosis. Its unique structure, characterized by the presence of a histidine-rich motif, indicates a potential for enzymatic activity that could influence cellular functions. Understanding the biochemical properties and regulatory mechanisms of HRASLS5 is crucial, as it could unveil novel therapeutic targets for treating disorders related to aberrant lipid metabolism and cancer. Additionally, the exploration of HRASLS5 in the context of metabolic pathways may shed light on its involvement in other diseases, making it a promising candidate for future research in molecular biology and therapeutic development.











